Abstract:AIM:To investigate the long-term outcome of recipients and donors of adult-to-adult living-donor liver transplantation (AALDLT) for acute liver failure (ALF).METHODS:Between January 2005 and March 2010, 170 living donor liver transplantations were performed at West China Hospital of Sichuan University. All living liver donor was voluntary and provided informed consent. Twenty ALF patients underwent AALDLT for rapid deterioration of liver function. ALF was defined based on the criteria of the American Association for the Study of Liver Diseases, including evidence of coagulation abnormality [international normalized ratio (INR) ≥ 1.5] and degree of mental alteration without pre-existing cirrhosis and with an illness of < 26 wk duration. We reviewed the clinical indications, operative procedure and prognosis of AALDTL performed on patients with ALF and corresponding living donors. The potential factors of recipient with ALF and corresponding donor outcome were respectively investigated using multivariate analysis. Survival rates after operation were analyzed using the Kaplan-Meier method. Receiver operator characteristic (ROC) curve analysis was undertaken to identify the threshold of potential risk factors.RESULTS:The causes of ALF were hepatitis B (n = 18), drug-induced (n = 1) and indeterminate (n = 1). The score of the model for end-stage liver disease was 37.1 ± 8.6, and the waiting duration of recipients was 5 ± 4 d. The graft types included right lobe (n = 17) and dual graft (n = 3). The mean graft weight was 623.3 ± 111.3 g, which corresponded to graft-to-recipient weight ratio of 0.95% ± 0.14%. The segment Vor VIII hepatic vein was reconstructed in 11 right-lobe grafts. The 1-year and 3-year recipient's survival and graft survival rates were 65% (13 of 20). Postoperative results of total bilirubin, INR and creatinine showed obvious improvements in the survived patients. However, the creatinine level of the deaths was increased postoperatively and became more aggravated compared with the level of the survived recipients. Multivariate analysis showed that waiting duration was independently correlated with increased mortality (P = 0.014). Furthermore, ROC curve revealed the cut-off value of waiting time was 5 d (P = 0.011, area under the curve = 0.791) for determining the mortality. The short-term creatinine level with different recipient's waiting duration was described. The recipients with waiting duration ≥ 5 d showed the worse renal function and higher mortality than those with waiting duration < 5 d (66.7% vs 9.1%, P = 0.017). In addition, all donors had no residual morbidity. Furthermore, univariate analysis did not show that short assessment time induced the high morbidity (P = 0.573).CONCLUSION:Timely AALDLT for patients with ALF greatly improves the recipient survival. However, further systemic review is needed to investigate the optimal treatment strategy for ALF.

Adult-to-adult Right-Lobe Living Donor Liver Transplantation in High Model for End-Stage Liver Disease Score Recipients with Hepatitis B Virus-Related Benign Liver Diseases

Emergent Right Lobe Adult-to-adult Living-Donor Liver Transplantation for High Model for End-Stage Liver Disease Score Severe Hepatitis.

Posttransplant Mortality Risk Assessment for Adult-to-adult Right-Lobe Living Donor Liver Recipients with Benign End-Stage Liver Disease

Clinical Study on Safety of Adult-to-adult Living Donor Liver Transplantation in Both Donors and Recipients

Adult-to-adult Living Donor Liver Transplantation Using Right Lobe Graft: Report of 24 Cases

Analysis of Fifty Adult to Adult Living Donor Liver Transplantation

[Clinical Study of Adult to Adult Living Donor Liver Transplantation: a Report of 56 Cases].

Benefit of living donor liver transplantation in graft survival for extremely high model for end-stage liver disease score ≥35

Adult-to-adult Living Donor Liver Transplantation with 94 Cases Report

Adult-to-adult Living Donor Liver Transplantation: a Report of 71 Cases

Does Model for End-Stage Liver Disease Score Predict the Short-Term Outcome of Living Donor Liver Transplantation?

Adult to adult right lobe living donor liver transplantation: does biological relationship matter?

New Prognostic Model For Adult-To-Adult Living Donor Liver Transplant Recipients

Safety of Donor in Adult-to-Adult Living Donor Liver Transplantation Using Right Lobe Graft

A Single Institution Experience with Living Donor Liver Transplantation for Acute-on-chronic Hepatitis B Liver Failure.

Outcomes of Hemi- Versus Whole Liver Transplantation in Patients from Mainland China with High Model for End-Stage Liver Disease Scores: a Matched Analysis

Adult-to-adult living donor liver transplantation: report of 3 cases

Outcome of using small-for-size grafts in living donor liver transplantation recipients with high model for end-stage liver disease scores: a single center experience.

Living Donor Liver Transplantation for End-Stage Liver Disease

Adult-to-adult Living Donor Liver Transplantation for Acute Liver Failure in China

Emergency Adult Living Donor Right Lobe Liver Transplantation for Fulminant Hepatic Failure